SUBSCRIBERS
Global pharma firms interested in local startup's new glaucoma treatment
Published Tue, Dec 9, 2014 · 09:50 PM
Singapore
"FIRST you have my interest, now you have my attention."
And that is what local biotech startup Peregrine Ophthalmic managed to do, in the words of associate professor Tina Wong, who was describing how a new glaucoma drug delivery solution developed by her 15-month-old startup has attracted inquiries from the world's top five pharmaceutical companies.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Technology
EU demands clarity from Microsoft on AI risks in Bing
Google focuses on security with next version of Android software
Are floating cities the solution to rising seas?
Apple scores win in labor case involving fired retail workers
Brokers’ take: DBS cuts Venture Corp price target after Q1 earnings miss
Garmin’s Q1 results beat on strong demand for fitness, auto products